Winton Group LTD Amphastar Pharmaceuticals, Inc. Transaction History

Winton Group LTD

$1.37 Billion
Q2 2024

A detailed history of Winton Group LTD transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Winton Group LTD holds 22,234 shares of AMPH stock, worth $1.14 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

22,234

Previous 20,581 8.03%

Holding current value

$1.14 Million

Previous $903,000 1.55%

% of portfolio

0.06%

Previous 0.07%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$38.65 - $43.48 $63,888 - $71,872	1,653 Added 8.03%	22,234 $889,000
Q1 2024 May 14, 2024	BUY	$42.85 - $63.45 $536,224 - $794,013	12,514 Added 155.13%	20,581 $903,000
Q4 2023 Feb 12, 2024	SELL	$44.49 - $62.93 $7,474 - $10,572	-168 Reduced 2.04%	8,067 $498,000
Q3 2023 Nov 13, 2023	SELL	$45.51 - $65.0 $73,908 - $105,560	-1,624 Reduced 16.47%	8,235 $378,000
Q2 2023 Aug 14, 2023	SELL	$35.77 - $58.38 $569,744 - $929,876	-15,928 Reduced 61.77%	9,859 $566,000
Q1 2023 May 12, 2023	SELL	$27.99 - $37.92 $163,209 - $221,111	-5,831 Reduced 18.44%	25,787 $967,000
Q4 2022 Feb 14, 2023	BUY	$27.93 - $31.27 $147,051 - $164,636	5,265 Added 19.98%	31,618 $885,000
Q3 2022 Nov 10, 2022	SELL	$27.56 - $37.75 $90,617 - $124,122	-3,288 Reduced 11.09%	26,353 $741,000
Q2 2022 Aug 10, 2022	BUY	$29.79 - $42.29 $384,886 - $546,386	12,920 Added 77.27%	29,641 $1.03 Million
Q1 2022 May 11, 2022	SELL	$22.96 - $36.45 $449,419 - $713,472	-19,574 Reduced 53.93%	16,721 $600,000
Q4 2021 Feb 10, 2022	SELL	$18.14 - $23.29 $399,642 - $513,101	-22,031 Reduced 37.77%	36,295 $845,000
Q3 2021 Oct 28, 2021	BUY	$17.83 - $21.49 $81,554 - $98,295	4,574 Added 8.51%	58,326 $1.11 Million
Q2 2021 Aug 10, 2021	BUY	$17.11 - $20.92 $68,200 - $83,387	3,986 Added 8.01%	53,752 $1.08 Million
Q1 2021 Jul 21, 2021	BUY	$17.21 - $20.65 $44,419 - $53,297	2,581 Added 5.47%	49,766 $912,000
Q4 2020 Feb 12, 2021	SELL	$17.76 - $21.24 $889,243 - $1.06 Million	-50,070 Reduced 51.48%	47,185 $949,000
Q3 2020 Oct 30, 2020	SELL	$17.99 - $22.22 $1.82 Million - $2.25 Million	-101,065 Reduced 50.96%	97,255 $1.82 Million
Q2 2020 Aug 05, 2020	BUY	$14.25 - $22.46 $1.65 Million - $2.6 Million	115,918 Added 140.67%	198,320 $4.45 Million
Q1 2020 May 11, 2020	SELL	$12.66 - $20.08 $130,094 - $206,342	-10,276 Reduced 11.09%	82,402 $1.22 Million
Q4 2019 Feb 13, 2020	BUY	$17.07 - $20.64 $1.31 Million - $1.59 Million	76,954 Added 489.4%	92,678 $1.79 Million
Q3 2019 Nov 08, 2019	BUY	$19.12 - $22.62 $300,642 - $355,676	15,724 New	15,724 $312,000
Q2 2019 Jul 08, 2019	SELL	$18.92 - $22.96 $222,896 - $270,491	-11,781 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$19.46 - $25.28 $229,258 - $297,823	11,781 New	11,781 $241,000

Others Institutions Holding AMPH

# of Institutions

280

Shares Held

34.8M

Call Options Held

25.5K

Put Options Held

24.8K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $2.51B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.

Account